Bhang Inc (BHNGF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Bhang Net Income (Quarterly): -0.9013M for Sept. 30, 2022
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | -0.9013M |
| June 30, 2022 | -1.098M |
| March 31, 2022 | -0.7436M |
| December 31, 2021 | -1.924M |
| September 30, 2021 | -0.6885M |
| June 30, 2021 | -0.7362M |
| March 31, 2021 | 0.0503M |
| December 31, 2020 | -0.9639M |
| September 30, 2020 | -2.272M |
| June 30, 2020 | -0.7912M |
| March 31, 2020 | -0.6189M |
| December 31, 2019 | -4.609M |
| September 30, 2019 | -8.794M |
| June 30, 2019 | -0.1459M |
| March 31, 2019 | -0.0197M |
| December 31, 2018 | -0.0796M |
| September 30, 2018 | -0.0423M |
| June 30, 2018 | 0.0404M |
| March 31, 2018 | -0.0857M |
| December 31, 2017 | 0.1794M |
| September 30, 2017 | -0.1522M |
| June 30, 2017 | 0.6449M |
| March 31, 2017 | -0.2559M |
| December 31, 2016 | -0.3303M |
| September 30, 2016 | 0.0959M |
| Date | Value |
|---|---|
| June 30, 2016 | -0.22M |
| March 31, 2016 | -0.4807M |
| December 31, 2015 | -0.2335M |
| September 30, 2015 | -0.562M |
| June 30, 2015 | -0.1517M |
| March 31, 2015 | -0.2265M |
| December 31, 2014 | -0.024M |
| September 30, 2014 | -0.3511M |
| June 30, 2014 | -0.2373M |
| March 31, 2014 | -0.3814M |
| December 31, 2013 | -0.2693M |
| September 30, 2013 | -0.8639M |
| June 30, 2013 | -0.1651M |
| March 31, 2013 | -0.1709M |
| December 31, 2012 | -0.058M |
| September 30, 2012 | -0.0375M |
| June 30, 2012 | -0.2944M |
| March 31, 2012 | -2.720M |
| December 31, 2011 | -0.4325M |
| September 30, 2011 | -0.0092M |
| June 30, 2011 | -0.0377M |
| March 31, 2011 | -1.179M |
| December 31, 2010 | -0.8525M |
| September 30, 2010 | -0.1727M |
| June 30, 2010 | -0.2123M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-8.794M
Minimum
Sep 2019
0.0503M
Maximum
Mar 2021
-1.853M
Average
-0.9013M
Median
Sep 2022
Net Income (Quarterly) Benchmarks
| Cantabio Pharmaceuticals Inc | 0.343M |
| Affymax Inc | -- |
| Scopus BioPharma Inc | -2.617M |
| Predictive Technology Group Inc | -7.387M |
| Statera BioPharma Inc | -3.349M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.3631M |
| Total Expenses (Quarterly) | 1.137M |
| EPS Diluted (Quarterly) | -0.0041 |